News
Let's look at five pharma and drug companies, PFE, LLY, AMGN, BIIB and REGN, which are scheduled to release their ...
1d
Zacks.com on MSNPuma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should KnowPuma Biotech (PBYI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Learn more about Anbio Biotechnology's (NNNN) stock grades for Value and determine whether this Biotechnology stock meets your investment needs.
Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses.
Chinese social media hints at U.S. outreach on trade, as President Trump’s tariffs continue to affect global markets. Follow along for live updates on the Dow, S&P 500, Nasdaq and other assets.
Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...
ImmunityBio, Inc. faces stock decline amid fundraising and market selloff. Click to read more on the long-term potential of ...
Eli Lilly shares dropped Thursday as Novo Nordisk notched a coverage win for its obesity drug, a sign of the competition in ...
We recently published a list of the 30 Stocks That Should Double in 3 Years. In this article, we are going to take a look at ...
Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...
1d
Investor's Business Daily on MSNArgenx Stock Extends Rally In A Base As Earnings LoomArgenx stock is rising Wednesday as the major indexes sell off. The autoimmune disease treatment stock is climbing in an early-stage base.
Alexandria Real Estate Equities faces numerous challenges amid a slumping life sciences real estate market, per its Q1 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results